These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 1728249

  • 1. Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers.
    Hollander E, DeCaria CM, Nitescu A, Gully R, Suckow RF, Cooper TB, Gorman JM, Klein DF, Liebowitz MR.
    Arch Gen Psychiatry; 1992 Jan; 49(1):21-8. PubMed ID: 1728249
    [Abstract] [Full Text] [Related]

  • 2. Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder.
    Pigott TA, Zohar J, Hill JL, Bernstein SE, Grover GN, Zohar-Kadouch RC, Murphy DL.
    Biol Psychiatry; 1991 Mar 01; 29(5):418-26. PubMed ID: 2018816
    [Abstract] [Full Text] [Related]

  • 3. Timing of neuroendocrine responses and effect of m-CPP and fenfluramine plasma levels in OCD.
    Hollander E, Cohen LJ, DeCaria C, Saoud JB, Stein DJ, Cooper TB, Islam NN, Liebowitz MR, Klein DF.
    Biol Psychiatry; 1993 Sep 15; 34(6):407-13. PubMed ID: 8218609
    [Abstract] [Full Text] [Related]

  • 4. Neuroendocrine and behavioral responses to mCPP in Obsessive-Compulsive Disorder.
    Khanna S, John JP, Reddy LP.
    Psychoneuroendocrinology; 2001 Feb 15; 26(2):209-23. PubMed ID: 11087965
    [Abstract] [Full Text] [Related]

  • 5. Cortisol response to d-fenfluramine in patients with obsessive-compulsive disorder and in healthy subjects: evidence for a gender-related effect.
    Monteleone P, Catapano F, Tortorella A, Maj M.
    Neuropsychobiology; 1997 Feb 15; 36(1):8-12. PubMed ID: 9211437
    [Abstract] [Full Text] [Related]

  • 6. Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findings.
    Hollander E, Fay M, Cohen B, Campeas R, Gorman JM, Liebowitz MR.
    Am J Psychiatry; 1988 Aug 15; 145(8):1015-7. PubMed ID: 2839998
    [Abstract] [Full Text] [Related]

  • 7. Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects.
    Charney DS, Goodman WK, Price LH, Woods SW, Rasmussen SA, Heninger GR.
    Arch Gen Psychiatry; 1988 Feb 15; 45(2):177-85. PubMed ID: 3337615
    [Abstract] [Full Text] [Related]

  • 8. Neuroendocrine and behavioral responses to challenge with the indirect serotonin agonist dl-fenfluramine in adults with obsessive-compulsive disorder.
    McBride PA, DeMeo MD, Sweeney JA, Halper J, Mann JJ, Shear MK.
    Biol Psychiatry; 1992 Jan 01; 31(1):19-34. PubMed ID: 1311964
    [Abstract] [Full Text] [Related]

  • 9. Cortisol and prolactin responses to d-fenfluramine in non-depressed patients with obsessive-compulsive disorder: a comparison with depressed and healthy controls.
    Lucey JV, O'Keane V, Butcher G, Clare AW, Dinan TG.
    Br J Psychiatry; 1992 Oct 01; 161():517-21. PubMed ID: 1393339
    [Abstract] [Full Text] [Related]

  • 10. Neuroendocrine responses to m-chlorophenylpiperazine and L-tryptophan in bulimia.
    Brewerton TD, Mueller EA, Lesem MD, Brandt HA, Quearry B, George DT, Murphy DL, Jimerson DC.
    Arch Gen Psychiatry; 1992 Nov 01; 49(11):852-61. PubMed ID: 1444722
    [Abstract] [Full Text] [Related]

  • 11. The anterior pituitary responds normally to protirelin in obsessive-compulsive disorder: evidence to support a neuroendocrine serotonergic deficit.
    Lucey JV, Butcher G, Clare AW, Dinan TG.
    Acta Psychiatr Scand; 1993 Jun 01; 87(6):384-8. PubMed ID: 8356888
    [Abstract] [Full Text] [Related]

  • 12. Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls.
    Zohar J, Mueller EA, Insel TR, Zohar-Kadouch RC, Murphy DL.
    Arch Gen Psychiatry; 1987 Nov 01; 44(11):946-51. PubMed ID: 3675134
    [Abstract] [Full Text] [Related]

  • 13. Serotonergic function in social phobia: comparison to normal control and obsessive-compulsive disorder subjects.
    Hollander E, Kwon J, Weiller F, Cohen L, Stein DJ, DeCaria C, Liebowitz M, Simeon D.
    Psychiatry Res; 1998 Jul 13; 79(3):213-7. PubMed ID: 9704868
    [Abstract] [Full Text] [Related]

  • 14. Serotonergic dissection of obsessive compulsive symptoms: a challenge study with m-chlorophenylpiperazine and sumatriptan.
    Gross-Isseroff R, Cohen R, Sasson Y, Voet H, Zohar J.
    Neuropsychobiology; 2004 Jul 13; 50(3):200-5. PubMed ID: 15365215
    [Abstract] [Full Text] [Related]

  • 15. Behavioral and neuroendocrine responses to metaCPP in anorexia nervosa.
    Hadigan CM, Walsh BT, Buttinger C, Hollander E.
    Biol Psychiatry; 1995 Apr 15; 37(8):504-11. PubMed ID: 7619973
    [Abstract] [Full Text] [Related]

  • 16. Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects.
    Broocks A, Meyer T, Gleiter CH, Hillmer-Vogel U, George A, Bartmann U, Bandelow B.
    Psychopharmacology (Berl); 2001 May 15; 155(3):234-41. PubMed ID: 11432685
    [Abstract] [Full Text] [Related]

  • 17. Acute intravenous administration of ondansetron and m-CPP, alone and in combination, in patients with obsessive-compulsive disorder (OCD): behavioral and biological results.
    Broocks A, Pigott TA, Hill JL, Canter S, Grady TA, L'Heureux F, Murphy DL.
    Psychiatry Res; 1998 Jun 02; 79(1):11-20. PubMed ID: 9676822
    [Abstract] [Full Text] [Related]

  • 18. Plasma prolactin response to d-fenfluramine in obsessive-compulsive patients before and after fluvoxamine treatment.
    Monteleone P, Catapano F, Bortolotti F, Maj M.
    Biol Psychiatry; 1997 Aug 01; 42(3):175-80. PubMed ID: 9232209
    [Abstract] [Full Text] [Related]

  • 19. Hormonal, psychological, and alcohol craving changes after m-chlorophenylpiperazine administration in alcoholics.
    Buydens-Branchey L, Branchey M, Fergeson P, Hudson J, McKernin C.
    Alcohol Clin Exp Res; 1997 Apr 01; 21(2):220-6. PubMed ID: 9113256
    [Abstract] [Full Text] [Related]

  • 20. Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects.
    Anand A, Charney DS, Delgado PL, McDougle CJ, Heninger GR, Price LH.
    Am J Psychiatry; 1994 Nov 01; 151(11):1626-30. PubMed ID: 7943451
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.